The Enterprise has developed a series of primers and vaccine trials factsheets to help a range of stakeholders to keep up with rapid changes in the field. We welcome comments and suggestions on how to improve these documents.
Established in 2003, the Global HIV Vaccine Enterprise (the Enterprise) became a programme of IAS – the International AIDS Society – in 2018. The Enterprise unites stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of – and future access to – an HIV vaccine.
Global HIV Vaccine Enterprise
IAS – the International AIDS Society
Avenue de France 23